Abstract:AbstractBackgroundTau tangles and amyloid plaques are specific biomarkers that define dementia of Alzheimer’s disease (AD). However, behavioral changes or neuropsychiatric symptoms (NPS) are the natural course of AD, which impact the patients’ quality of life and caregivers’ burdens. Relationship between tau tangles or changes of cortical thickness and ‘noncognitive’ symptoms such as behavioral changes were understudied.Method497 subjects were selected from Alzheimer’s Disease Neuroimaging Initiative (ADNI) project. Participants underwent tau positron emission tomographic (PET) scanning with 18F AV‐1451, Aβ PET scanning with florbetapir or florbetaben, magnetic resonance imaging, and cognitive and behavioral testing. A 4‐group division approach was proposed using both amyloid (A‐/A+) and behavior (B‐/B+) status: A‐B‐, A‐B+, A+B‐ and A+B+. Multivariable linear regression model was used to delineate the relationship of tauopathy/neurodegeneration and cognitive decline for each group.ResultThe tau deposition increased significantly from the A‐ group to the A+ group, and the associated regions spread into nearly the whole brain. No correlations of the cortical thickness with cognitive decline were found for both the A‐ and A+ groups. Considering the behavior status, no associations were found for both the A‐B‐ group and the A+B‐ group. The association of cognitive decline with tau deposition was observed in the temporal lobe (entorhinal cortex, para‐hippocampal gyrus, et., al) for the A‐B+ group and spread into nearly the whole cerebrum for the A+B+ group. For cortical thickness, the associations with cognitive decline show similar spreading patterns of tau deposition for the A‐B+ group while nearly no difference of the associated regions for the A+B+ group.ConclusionThe association of cognitive decline with tauopathy/neurodegeneration were driven by the subjects with abnormal behavior status (B+ groups), while there were nearly no associations for B‐ groups (A‐ and A+). NPS may have the ability to improve the differentiation sensitivity of Aβ on the severity of tauopathy/neurodegeneration. Several factors such as tau tangles, amyloid plaques, cortical atrophy, and behavior symptoms should be considered together for neuropsychiatric disorder diagnosis.

Behavioral and Psychological Symptoms in Alzheimer's Disease.

The neural basis of neuropsychiatric symptoms in Alzheimer's disease

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer’s Disease: a Systematic Review of Symptom-General and –specific Lesion Patterns

Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease

Beyond memory impairment: the complex phenotypic landscape of Alzheimer's disease

Characteristics of neuropsychiatric symptoms among individuals with Alzheimer's disease in a memory clinic setting

Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline

The Prevalence Of Neuropsychiatric Symptoms In Alzheimer'S Disease: Systematic Review And Meta-Analysis (Vol 190, Pg 264, 2016)

Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients

P3-459: Neuropsychiatric Features in Alzheimer's Disease and Mild Cognitive Impairment in Memory Clinic

Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals

Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms

Behavior and Amyloid Profiles Modify the Association of Tauopathy/neurodegeneration and Cognitive Decline in Alzheimer’s Disease

Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease

Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?

Cerebrospinal fluid amyloid-β and cerebral microbleed are associated with distinct neuropsychiatric sub-syndromes in cognitively impaired patients

An Updated Review Focusing on Alzheimer's Disease

The severity of neuropsychiatric symptoms is higher in early‐onset than late‐onset Alzheimer’s disease

Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress